$ALXN ALEXION PHARMACEUTICALS, INC. Insider Trading Week 20/2020
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ALEXION PHARMACEUTICALS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in ALEXION PHARMACEUTICALS, INC. in week 20/2020.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 18 2020 | ALXN | ALEXION PHARMACEUT ... | BAKER BROS. ADVISORS LP | Director | Grant | A | 0.00 | 1,189 | 0 | 7,846,213 | 7.8 M to 7.8 M (+0.02 %) |
May 18 2020 | ALXN | ALEXION PHARMACEUT ... | BAKER BROS. ADVISORS LP | Director | Grant | A | 0.00 | 1,189 | 0 | 998,953 | 997.8 K to 999 K (+0.12 %) |
May 18 2020 | ALXN | ALEXION PHARMACEUT ... | BAKER BROS. ADVISORS LP | Director | Grant | A | 0.00 | 3,468 | 0 | 7,845,024 | 7.8 M to 7.8 M (+0.04 %) |
May 18 2020 | ALXN | ALEXION PHARMACEUT ... | BAKER BROS. ADVISORS LP | Director | Grant | A | 0.00 | 3,468 | 0 | 997,764 | 994.3 K to 997.8 K (+0.35 %) |
May 18 2020 | ALXN | ALEXION PHARMACEUT ... | Brennan David R | Director | Grant | A | 0.00 | 2,428 | 0 | 17,537 | 15.1 K to 17.5 K (+16.07 %) |
May 18 2020 | ALXN | ALEXION PHARMACEUT ... | Brennan David R | Director | Grant | A | 0.00 | 3,468 | 0 | 15,109 | 11.6 K to 15.1 K (+29.79 %) |
May 18 2020 | ALXN | ALEXION PHARMACEUT ... | Rummelt Andreas | Director | Grant | A | 0.00 | 3,468 | 0 | 25,614 | 22.1 K to 25.6 K (+15.66 %) |
May 18 2020 | ALXN | ALEXION PHARMACEUT ... | Mollen John T | Director | Grant | A | 0.00 | 3,468 | 0 | 12,701 | 9.2 K to 12.7 K (+37.56 %) |
May 18 2020 | ALXN | ALEXION PHARMACEUT ... | Reinsdorf Judith A | Director | Grant | A | 0.00 | 595 | 0 | 11,515 | 10.9 K to 11.5 K (+5.45 %) |
May 18 2020 | ALXN | ALEXION PHARMACEUT ... | Reinsdorf Judith A | Director | Grant | A | 0.00 | 3,468 | 0 | 10,920 | 7.5 K to 10.9 K (+46.54 %) |
May 18 2020 | ALXN | ALEXION PHARMACEUT ... | COUGHLIN CHRISTOPHER J | Director | Grant | A | 0.00 | 2,774 | 0 | 39,656 | 36.9 K to 39.7 K (+7.52 %) |
May 18 2020 | ALXN | ALEXION PHARMACEUT ... | COUGHLIN CHRISTOPHER J | Director | Grant | A | 0.00 | 3,468 | 0 | 36,882 | 33.4 K to 36.9 K (+10.38 %) |
May 18 2020 | ALXN | ALEXION PHARMACEUT ... | Nader Francois | Director | Grant | A | 0.00 | 941 | 0 | 11,286 | 10.3 K to 11.3 K (+9.10 %) |
May 18 2020 | ALXN | ALEXION PHARMACEUT ... | Nader Francois | Director | Grant | A | 0.00 | 3,468 | 0 | 10,345 | 6.9 K to 10.3 K (+50.43 %) |
May 18 2020 | ALXN | ALEXION PHARMACEUT ... | FRIEDMAN PAUL A | Director | Grant | A | 0.00 | 3,468 | 0 | 10,345 | 6.9 K to 10.3 K (+50.43 %) |
May 18 2020 | ALXN | ALEXION PHARMACEUT ... | Dunsire Deborah | Director | Grant | A | 0.00 | 941 | 0 | 12,134 | 11.2 K to 12.1 K (+8.41 %) |
May 18 2020 | ALXN | ALEXION PHARMACEUT ... | Dunsire Deborah | Director | Grant | A | 0.00 | 3,468 | 0 | 11,193 | 7.7 K to 11.2 K (+44.89 %) |